dpp 4 inhibitor and glp 1 agonist Were DPP-4 inhibitors the original GLP-1s? do not combine dpp-4 inhibitors
Description
Obesity is a chronic illness, just like diabetes and cardiovascular disease, Basilico and experts like her agree

F.LingvayI.et al (2021)

Concentration Risk

According to primary trials in T2DM, tirzepatide significantly reduces clinical outcomes like body weight, glycated hemoglobin (HbA1c), lipid profiles, and glucose-adjusted glucagon secretion compared to typical glucagon-like peptide1 receptor agonists (GLP1RAs) [1, 2]

By directly acting on appetite circuits in the brain, GLP-1 may cause people to experience less hunger
